# Phase 1 Release Note

## Phase Scope

Phase 1 established a lightweight public collaboration baseline for Trust-Bounded Agent OS before any Action Spine MVP implementation work.

The phase covered:

- lightweight Human / ChatGPT / Codex collaboration controls;
- the smallest mock-only Action Spine MVP slice;
- one static mock Action Spine proposal example;
- a friction-log mechanism for later process review.

## PRs Included

- PR #1: collaboration baseline.
- PR #2: mock-only Action Spine MVP slice and friction log.
- PR #3: static mock Action Spine proposal example.

## Files Added Or Updated

- `AGENTS.md`
- `docs/development-log/current-task-context.md`
- `docs/development-log/current-task-status.md`
- `docs/development-log/friction-log.md`
- `docs/development-log/action-spine-mvp-slice.md`
- `docs/development-log/action-spine-static-mock-example.md`

## What Was Established

Phase 1 established an operating baseline that asks Codex to avoid full-repository scans by default, read current task context first, keep PRs narrow, use PR body notes for intermediate evidence, and reserve final evidence for phase end.

It also defined the next Action Spine work as a static, local-only, mock-only, non-executing proposal path. The static mock example includes intent, proposed action, risk tier, required confirmation token, `execution_status: not_executed`, and an audit note.

## Safety Boundaries Preserved

Phase 1 preserved:

- local-only;
- mock-only;
- non-executing;
- no real credentials;
- no real funds;
- no real external side effects;
- no runtime execution;
- no live API;
- no scheduler;
- no worker;
- no production plugin activation;
- no production-readiness claim.

## What Was Deliberately Not Done

Phase 1 deliberately did not add:

- runtime implementation;
- scripts;
- tests;
- package files;
- `src/`;
- `examples/`;
- live integrations;
- real file writes;
- Action Spine execution;
- expansion into PET/KET, OKX, trading, health, legal, or personal-data runtime scenarios.

## Evidence Summary

Evidence for Phase 1 is intentionally lightweight. Each PR body recorded narrow file-diff checks and grep-style boundary checks for production-readiness language, credential/funds/external-side-effect language, and runtime or execution-related terms.

This note does not duplicate every validation output. It records that Phase 1 review evidence was kept in PR bodies rather than expanded into a long evidence report.

## Known Limitations

- The current example is static documentation only.
- No executable verification exists yet.
- The risk tier is illustrative, not a finalized taxonomy.
- The confirmation token is illustrative and does not unlock behavior.
- This phase proves scope discipline, not runtime capability.

## Next Phase Recommendation

Pause for human review before Phase 2.

If Phase 2 starts, first decide whether to:

- continue in docs only; or
- introduce a static non-executing fixture, still without runtime code.

## Stop Condition

Phase 1 stops after PR #4.

Do not continue adding feature PRs without human review.
